insights_auto
Prečo akcie 2U3 stúpli 2,34%?
Preskúmať podrobnejšiechevron_right
2U3:FRA
Alcon AG
56,92 €
arrow_upward
+2,34%(+1,30) 1 d.
9. 10., 22:00:00 GMT+2 · EUR
search
Všetky symboly
| Symbol | Cena | Zmena | % zmeny |
|---|
insights_autoGenerujú sa najdôležitejšie štatistiky pre 2U3…
Otvoriť
56,38 €
Vysoká
56,92 €
Nízka
56,38 €
Trh. kap.
26,50 mld.
Priem. obj.
138,00
Objem
303,00
Max. za 52 týž.
73,96 €
Min. za 52 týž.
51,78 €
Počet zamestnancov
25 tis.
Otvoriť
56,38 €
Vysoká
56,92 €
Nízka
56,38 €
Trh. kap.
26,50 mld.
Priem. obj.
138,00
Objem
303,00
Max. za 52 týž.
73,96 €
Min. za 52 týž.
51,78 €
Počet zamestnancov
25 tis.
Spravodajstvo
Z internetových zdrojov a od spravodajských partnerov
Simply Wall Street
·
pred 17 hodinami
What Alcon Shares Launch Of New Dry Eye Drops In Canada Means For Shareholders
AD HOC NEWS
·
pred 20 hodinami
Alcon stock is unchanged at EUR 57.25 as AAO 2026 begins
AD HOC NEWS
·
pred 1 dňom
Alcon stock trades at EUR 57.02 with CHF 25.9 billion market value
AD HOC NEWS
·
pred 1 dňom
Alcon presents Academy research. Alcon stock gains 1.17 percent
Profil
Alcon Inc. is a Swiss-American pharmaceutical and medical device company specializing in eye care products. Alcon is incorporated in the Canton of Fribourg, Switzerland, and its global headquarters are located in Geneva, but its main operational base is in Fort Worth, Texas, United States, where it employs about 4,500 people.
Alcon was a subsidiary of Novartis until April 2019, when it was spun out into a separate publicly traded company. Alcon itself has a number of subsidiaries, including Aerie Pharmaceuticals, focused on therapies for glaucoma and other diseases of the eye, and WaveLight, which develops and manufactures laser eye surgery technologies. Wikipedia
Informácie o subjekte Alcon AG
Generálny riaditeľDavid J. Endicott
Zamestnanci25 tis.
Dátum založenia1945
Hlavné sídloŽeneva, Ženeva, Švajčiarsko
Odvetvie-
Webalcon.com